JQ1 molecular study for cancer treatment

Scientists have continually tried to find many measures to prevent the spread of malignant tumors.

>>>Breakthrough in immunotherapy for cancer cells

Image for illustrative purposes. (internet source) The international team of scientists at Dana Farber Cancer Research Institute (USA) has studied a type of JQ1 molecule that can make the cancer gene ineffective, thereby basically inhibiting birth. Head of the tumor.

The research results show that the JQ1 molecule is a " epigenetic genome " created by the combination of many different molecules, which can affect the multistage mechanism of the cell, thereby generating the Genetic control.

JQ1 molecule has two functions. First, lock out abnormal proteins in NMC cancer cells (the type of cancer caused by the "position change " of chromosomes). Secondly, it is possible to block the abnormal protein replication in NMC cancer cells, causing this protein to " forget its identity " in cancer cells and gradually restore normal cells.

Scientists implanted NMC cancer cells on the patient's body into mice, and also used JQ1 molecules in experimental mice. The results showed that all mice that were treated with JQ1 molecules survived, while those that were not treated with JQ1 molecules died.

In the short term, scientists are working to reverse the shape of the JQ1 molecule to promote its greatest efficiency.

According to scientists, because it is possible to selectively select molecules into cancer cell proteins, so the molecule has the effect of blocking the cancer process, thereby reducing the side effects to the minimum. .

The development of JQ1 molecules or molecular drugs can help create specialized therapies for people with NMC, and help create new methods in the treatment of cancer.